首页 | 本学科首页   官方微博 | 高级检索  
检索        

NQO1过表达在卵巢黏液性囊腺癌预后评估中的意义
引用本文:徐明,杨洋,车拴龙,朴英实,林贞花,陈丽艳.NQO1过表达在卵巢黏液性囊腺癌预后评估中的意义[J].中国病理生理杂志,2016,32(8):1461-1465.
作者姓名:徐明  杨洋  车拴龙  朴英实  林贞花  陈丽艳
作者单位:1. 延边大学医学院病理学教研室, 吉林 延吉 133002;
2. 延边大学肿瘤研究中心, 吉林 延吉 133002
基金项目:国家自然科学基金资助项目(No.81460399)
摘    要:目的:探讨NAD(P)H醌氧化还原酶1NAD(P)H-quinone oxidoreductase 1,NQO1]过表达在卵巢黏液性囊腺癌临床预后评估中的意义。方法:应用免疫组化En Vision法检测NQO1蛋白在162例卵巢黏液性囊腺癌组织、35例卵巢黏液性囊腺瘤组织和29例正常卵巢上皮组织中的表达,并分析其过表达与卵巢黏液性囊腺癌临床病理学特点之间的关系,通过Kaplan-Meier方法进行生存分析。结果:NQO1蛋白在卵巢黏液性囊腺癌组织中的阳性率及强阳性率分别为85.8%和64.2%,显著高于卵巢黏液性囊腺瘤和正常卵巢上皮组织(P0.01)。卡方检验结果显示,NQO1蛋白高表达与卵巢黏液性囊腺癌组织学分级和FIGO分期密切相关(P0.05)。Kaplan-Meier生存分析显示,NQO1蛋白高表达的卵巢黏液性囊腺癌患者总生存期和无病生存期均明显低于NQO1蛋白低表达患者。结论:NQO1蛋白在卵巢黏液性囊腺癌组织中呈高表达,可能成为卵巢黏液性囊腺癌预后评估的有效生物学指标。

关 键 词:卵巢黏液性囊腺癌  NAD(P)H醌氧化还原酶1  免疫组化  无病生存期  预后  
收稿时间:2016-03-03

Prognostic significance of NAD(P)H-quinone oxidoreductase 1 overexpression in ovarian mucinous cystadenocarcinoma
XU Ming,YANG Yang,CHE Shuan-long,PIAO Ying-shi,LIN Zhen-hua,CHEN Li-yan.Prognostic significance of NAD(P)H-quinone oxidoreductase 1 overexpression in ovarian mucinous cystadenocarcinoma[J].Chinese Journal of Pathophysiology,2016,32(8):1461-1465.
Authors:XU Ming  YANG Yang  CHE Shuan-long  PIAO Ying-shi  LIN Zhen-hua  CHEN Li-yan
Institution:1. Department of Pathology, Medical College, Yanbian University, Yanji 133002, China;
2. Cancer Research Center, Yanbian University, Yanji 133002, China
Abstract:AIM: To investigate the significance of NAD(P) H-quinone oxidoreductase 1 (NQO1) protein overexpression for prognostic evaluation of ovarian mucinous cystadenocarcinoma.METHODS: NQO1 protein was detected in 162 cases of ovarian mucinous cystadenocarcinoma, 35 cases of ovarian mucinous cystadenoma and 29 samples of normal ovarian epithelial tissues by the method of EnVision immunohistochemical staining. The correlation between high expression of NQO1 protein and clinicopathological features of ovarian mucinous cystadenocarcinoma was also evaluated. Overall survival and disease-free survival rates of ovarian mucinous cystadenocarcinoma patients were calculated by Kaplan-Meier method. RESULTS: The positive rate and strongly positive rate of NQO1 protein were 85.8% and 64.2% in ovarian mucinous cystadenocarcinoma, respectively, which are significantly higher than those in ovarian mucinous cystadenoma, and normal ovarian epithelial tissues (P<0.01). NQO1 expression was significantly correlated with the histological grade (P<0.05) and clinical stage (P<0.01) of ovarian mucinous cystadenocarcinoma. Kaplan-Meier survival analysis showed that the overall survival rate and disease-free survival rate were significantly higher in ovarian mucinous cystadenocarcinoma patients with high NQO1 expression than those with low NQO1 expression (P<0.01).CONCLUSION: NQO1 expression is closely correlated with the progression and prognosis of the patients with ovarian mucinous cystadenocarcinoma. High expression of NQO1 protein may be used as an important indicator for the patients with poor prognosis of ovarian mucinous cystadenocarcinoma.
Keywords:Ovarian mucinous cystadenocarcinoma  NAD(P) H-quinone oxidoreductase 1  Immunohistochemistry  Disease-free survival  Prognosis
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号